Alpharetta, GA, United States of America

Michael G Natchus

USPTO Granted Patents = 53 


 

Average Co-Inventor Count = 5.6

ph-index = 9

Forward Citations = 257(Granted Patents)

Forward Citations (Not Self Cited) = 228(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Cincinnati, OH (US) (1997)
  • Glendale, OH (US) (2000 - 2005)
  • Alpharetta, CA (US) (2015)
  • Alpharetta, GA (US) (2004 - 2024)

Company Filing History:


Years Active: 1997-2025

Loading Chart...
Loading Chart...
Loading Chart...
53 patents (USPTO):Explore Patents

Title: Unveiling the Inventive Journey of Michael G Natchus

Introduction:

In the realm of innovation and patents resides Michael G Natchus, a prolific inventor hailing from Alpharetta, Georgia, US. With an impressive portfolio of 50 patents under his belt, Michael G Natchus has made significant contributions to the fields of pharmaceuticals and endocrine dysfunction treatment.

Latest Patents:

Among his latest patents is the groundbreaking invention of N4-hydroxycytidine derivatives and their anti-viral applications. This innovation opens new avenues in the treatment and prevention of various viral infections, including but not limited to Eastern, Western, and Venezuelan Equine Encephalitis, Chikungunya fever, Ebola, Influenza, RSV, and Zika virus infections. Additionally, Michael G Natchus has introduced tricyclic amino containing compounds for alleviating symptoms associated with endocrine dysfunction, particularly hot flashes.

Career Highlights:

Having honed his expertise at esteemed institutions, Michael G Natchus has lent his innovative prowess to companies such as The Procter & Gamble Company and Emory University. His unique insights and inventive spirit have fueled the development of novel pharmaceutical compositions and treatment methods, showcasing his commitment to advancing healthcare solutions.

Collaborations:

In his collaborative endeavors, Michael G Natchus has worked alongside notable peers in the industry, including Biswanath De and Neil Gregory Almstead. Through shared expertise and collective ingenuity, these collaborations have paved the way for cutting-edge advancements in the realm of pharmaceuticals and endocrine dysfunction treatment.

Conclusion:

Michael G Natchus stands as a beacon of innovation and inventiveness in the competitive landscape of patents and inventions. With a profound impact on healthcare innovation, his patented inventions continue to transform the way we combat viral infections and address symptoms of endocrine dysfunction. As he continues his inventive journey, the world eagerly anticipates the next wave of groundbreaking solutions from this visionary inventor.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…